(Q81488440)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

An analytical framework for immunization programs in Canada (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

Erickson LJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

De Wals P

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Farand L

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2470-2476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

Access to vaccines: A call to action

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Cost of chickenpox in Canada: part I. Cost of uncomplicated cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program-Active (IMPACT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Burden of chickenpox on families: A study in Quebec.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Epidemiological and economic burden of pneumococcal diseases in Canadian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Pertussis is a frequent cause of prolonged cough illness in adults and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

The changing age and seasonal profile of pertussis in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Morbidity of pertussis in adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Effectiveness and cost-benefit of an influenza vaccination program for health care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

A benefit-cost analysis of two-dose measles immunization in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

The cost-effectiveness of varicella vaccination in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Instituting a routine varicella vaccination program in Canada: an economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Cost-utility analyses of clinical preventive services: published ratios, 1976-1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

Are we giving too many doses of hepatitis A and B vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

The effect of vaccination on the epidemiology of varicella zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.029

10.1016/J.VACCINE.2004.10.029

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752833%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference